Clinical trials
Phase 1 Acromegaly trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 2 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ono Pharmaceutical Co., Ltd. | 2 |
| Azidus Brasil | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Debiopharm International SA | 1 |
| Endocrinology Research Centre, Moscow | 1 |
| Immunwork, Inc. | 1 |
| Marea Therapeutics | 1 |
| Novartis Pharmaceuticals | 1 |
| Triastek (Shanghai) Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 10 |
| Carcinoid Tumor | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Hyperparathyroidism, Primary | 1 |
| Pituitary ACTH Hypersecretion | 1 |
| Vitamin D Deficiency | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.